Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world evidence of the effectiveness of a treat-to-target (T2T) approach based on faecal calprotectin (FC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback